Day: May 4, 2020

Increased Net Sales 10.1 percent to $257.7 millionReported Net Income per Diluted Share of $0.15Delivered Adjusted Net Income per Diluted Share of $0.15ATLANTA, May 04, 2020 (GLOBE NEWSWIRE) — Mueller Water Products, Inc. (NYSE: MWA) announced today that for its fiscal 2020 second quarter ended March 31, 2020, net sales were $257.7 million and net income was $23.8 million.In the 2020 second quarter, the Company:Increased net sales 10.1 percent to $257.7 million as compared with $234.0 million in the prior year quarter.Generated operating income of $35.8 million as compared with $22.2 million in the prior year quarter.  Increased adjusted operating income 17.3 percent to $36.7 million as compared with $31.3 million in the prior year quarter.Achieved net income of $23.8 million as compared with net income of $10.9 million in the prior...

Re-opening 20 Retail Stores Credit Line Increased to $150 MillionMOUNT HOREB, Wis., May 04, 2020 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or “Company”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s casual wear, workwear and accessories, today provided a business update and announced a partnership with American Red Cross:Partnership with American Red Cross to donate portion of proceeds on key apparel itemsRe-opening of 20 retail stores today where COVID-19 restrictions have been lifted and preparing to re-open the balance as other states lift their pandemic mandatesLaunched new women’s campaign celebrating “forge their way” inspirational womenAmended and expanded line of credit closed on April 30Partnered with landlords, suppliers and vendors to materially reduce costs, extend...

TORONTO, May 04, 2020 (GLOBE NEWSWIRE) — Dealnet Capital Corp. (“Dealnet” or the “Company”) (TSX VENTURE: DLS) announces that it has received materials from a group of dissident shareholders, led by former Dealnet Executive Chairman and current Capital Partners CEO, Dr. Steven Small (“Small”), requisitioning a meeting of the Company’s shareholders.The Small Dissident Group previously put forward the same four dissident director nominees for election to the Board of Directors at the Company’s 2020 annual general meeting, and Dealnet has provided disclosure regarding Small’s time at the helm of the Company and how the new leadership team moved with skill and discipline to fully address the legacy issues he created. Shareholders are urged to review the disclosure at www.dealnetcapital.com/2020-news/ and the investor presentation...

First Quarter 2020 Highlights (as compared to prior year quarter):Net sales increased 2.8% to $203.0 millionGross margin increased 120 basis points to 20.1% compared to 18.9%Operating loss $7.6 million; exclusive of $9.5 million goodwill impairment charge, operating income increased $4.1 million to $1.9 million compared to a loss of ($2.2) millionAdjusted EBITDA of $3.5 million compared to ($0.3) millionTotal liquidity increased to $55.4 million compared to $53.0 millionST. LOUIS, May 04, 2020 (GLOBE NEWSWIRE) — Huttig Building Products, Inc. (“Huttig” or the “Company”) (NASDAQ: HBP), a leading domestic distributor of millwork, building materials and wood products, today reported financial results for the first quarter ended March 31, 2020, and provided a business update on its response to the COVID-19 pandemic.“Our first quarter...

VANCOUVER, Colombie-Britannique, 04 mai 2020 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V/ASX : EMN) (la « société » ou « EMN ») a le plaisir d’annoncer que lors d’une assemblée extraordinaire des actionnaires (l’« assemblée ») qui s’est tenue le 1er mai 2020, les actionnaires ont voté en faveur de chacune des neuf résolutions approuvant la souscription par les personnes morales ou physiques apparentées d’actions ordinaires de la société (les « actions ») comme exigé par les règles de cotation 15.1 et 15.1.4 de la Bourse australienne des valeurs mobilières (« ASX »).  La souscription d’actions ou de titres de dépôt CHESS (« CDI ») par des personnes morales ou physiques apparentées (comprenant des administrateurs de la société et des sociétés contrôlées par ceux-ci) représente la deuxième tranche...

VANCOUVER, British Columbia, May 04, 2020 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V/ASX: EMN) (das „Unternehmen“ oder „EMN“) freut sich, bekannt zu geben, dass bei der außerordentlichen Aktionärsversammlung (die „Versammlung“), die am 1. Mai 2020 abgehalten wurde, die Aktionäre für alle neun Beschlüsse gestimmt und somit der Zeichnung von Stammaktien des Unternehmens („Aktien“) durch verbundene Parteien gemäß den Listing Rules 15.1 und 15.1.4 der Australian Securities Exchange („ASX“) zugestimmt haben.  Die Zeichnung von Aktien oder CHESS Depositary Interests („CDIs“) durch verbundene Parteien (Vorstandsmitglieder des Unternehmens und Unternehmen, die von Vorstandsmitgliedern des Unternehmens beherrscht werden) ist die zweite Tranche (die „Tranche für verbundene Parteien“) der nicht durch einen Makler vermittelten Privatplatzierung...

NASHVILLE, Tenn., May 04, 2020 (GLOBE NEWSWIRE) — CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ: CSTR) announced today the hiring of Michael J. Fowler as Chief Financial Officer.  He will report to Timothy K. Schools, CapStar’s President and Chief Executive Officer.  Fowler will succeed Robert B. Anderson who will remain with CapStar through June 30, 2020 to ensure a smooth transition.“Mike’s experiences will prove invaluable as we work to continue to enhance profitability, earnings consistency, and expand our growth opportunities,” said Schools.  “CapStar has a tremendous future and Mike’s reputation nationally for balance sheet management and contribution to scaling growth-oriented regional banks will be a great asset.”“I would like to thank Rob for his many contributions over the last seven...

— Robust efficacy and evidence of a dose response from single intravitreal injection (IVT) of ADVM-022 —— Long-term durability beyond 1 year from single IVT injection of ADVM-022 with zero rescue injections in Cohort 1 —— Encouraging early data from Cohort 3 —— Company to host a conference call and webcast with key opinion leaders today at 2:15 pm PDT —REDWOOD CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced new interim clinical data from Cohorts 1-3 of the OPTIC Phase 1 dose-ranging clinical trial of ADVM-022 intravitreal (IVT) injection gene therapy in patients requiring frequent anti-VEGF injections for their wet age-related...